Regenxbio Inc share price logo

Regenxbio Inc Share Price

NASDAQ: RGNX

Small Cap

$9.10

-0.10

(-1.09%)

as on

Regenxbio Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $8.85
    $9.35
    downward going graph

    2.75%

    Downside

    2.75%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.04
    $13.48
    downward going graph

    44.67%

    Downside

    48.13%

    Upside

    downward going graph

Regenxbio Inc share price movements today

Previous Close
$9.20
Open
$9.19
Volume
647.3K
Day's Low - High
$8.85 - $9.35
52 Week Low - High
$5.04 - $13.48

Regenxbio Inc Historical Returns

1 Month Return
+ 4.31 %
3 Month Return
-0.76 %
1 Year Return
-28.35 %
3 Year Return
-65.84 %
5 Year Return
-68.46 %

Regenxbio Inc Stock Fundamentals & Key Indicators

Check Regenxbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$464.7M

EPS (TTM)

-2.1283

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.46

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0.26

EBITDA

-148.8M

Revenue (TTM)

155.8M

Profit Margin

-112.70%

Return On Equity TTM

53765300.00%

Regenxbio Inc Stock Valuation

Track how Regenxbio Inc P/E has moved over time to understand its valuation trends.

Regenxbio Inc in the last 5 years

  • Overview

  • Trends

Lowest (12.43x)

December 31, 2021

Industry (-3.85x)

September 15, 2025

Today (-2.46x)

September 15, 2025

Highest (19.14x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -2.46x

Regenxbio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Regenxbio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$464.7M-68.46%-2.46-112.70%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Regenxbio Inc Stock including INR - Dollar returns

The Regenxbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Regenxbio Inc investment value today

Current value as on today

₹75,858

Returns

₹24,142

(-24.14%)

Returns from Regenxbio Inc Stock

₹29,128 (-29.13%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Regenxbio Inc Stock

Based on 18 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Regenxbio Inc. Average target price of $29.75

Regenxbio Inc Share Price Target

Get share price movements and forecasts by analysts on Regenxbio Inc.

What analysts predicted

69.41%UPSIDE

Target Price

$29.75

Current Price

$9.1

Analyzed by

18 Analysts

Target

$29.75

Regenxbio Inc target price $29.75, a slight upside of 69.41% compared to current price of $9.1. According to 18 analysts rating.

Regenxbio Inc Stock's Interest Amongst Investors

Search interest for Regenxbio Inc Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Regenxbio Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
19
19
28
22
15
22
24
21
89
21
Gross Profit
15
10
16
6
7
7
11
14
85
12
Operating Income
-66
-73
-64
-63
-61
-56
-62
-51
12
-63
EBITDA
-59
-66
-55
-57
-57
-48
-54
-37
18
-55
Interest Expense
2
1
1
1
1
0
0
9
8
10
Depreciation
4
4
4
4
4
4
3
4
3
3
Income Before Tax
-66
-72
-61
-63
-63
-52
-59
-51
6
-70
Income Tax Expense
3
1
-2
0
0
-
-
-
-
-
Net Income
-69
-72
-61
-62
-63
-52
-59
-51
6
-70
Net Profit Margin
-365.50%
-360.72%
-213.97%
-283.12%
-405.39%
-237.67%
-246.30%
-241.28%
6.83%
-331.81%

Regenxbio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
7
4
10
218
35
154
470
112
90
83
Gross Profit
6
3
8
208
26
118
418
58
53
49
Operating Income
-23
-65
-75
88
-148
-119
159
-262
-268
-233
EBITDA
-22
-64
-73
92
-90
-96
169
-244
-239
-198
Interest Expense
0
-
-
-
107
0
26
23
6
12
Depreciation
-
-
2
3
7
8
9
12
17
16
Income Before Tax
-22
-63
-73
104
-97
-106
141
-280
-263
-227
Income Tax Expense
0
0
0
4
-2
5
13
0
0
-
Net Income
-22
-62
-73
99
-94
-111
127
-280
-263
-227
Net Profit Margin
-300.62%
-1372.13%
-704.02%
45.74%
-268.88%
-71.98%
27.18%
-248.68%
-291.99%
-272.54%

Regenxbio Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-72
-61
-62
-63
-52
-59
-51
6
-70
Operating Cash Flow
-47
-49
-40
-55
-45
-40
-31
33
-49
Investing Cash Flow
55
38
33
13
0
50
40
44
-140
Financing Cash Flow
-9
-4
-11
120
-9
-10
-7
-5
139
Change in Cash
-1
-15
-18
78
-55
0
0
72
-50

Regenxbio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-62
-73
99
-94
-111
127
-280
-263
-227
Operating Cash Flow
-48
-57
104
-107
-54
218
-207
-218
-173
Investing Cash Flow
19
-4
-279
93
122
-406
-11
190
103
Financing Cash Flow
0
84
204
8
200
195
-28
-34
92
Change in Cash
-29
21
29
-5
268
7
-248
-62
23

Global Institutional Holdings in Regenxbio Inc

Funds
Holdings
BlackRock Inc
10.8%
Redmile Group, LLC
9.49%
JPMorgan Chase & Co
8.64%
Vanguard Group Inc
6.88%
Morgan Stanley - Brokerage Accounts
4.09%

Insights on Regenxbio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 189.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 103.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 89.01M → 21.35M (in $), with an average decrease of 76.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 6.08M → -70.87M (in $), with an average decrease of 1265.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RGNX stock has moved down by -3.0%

About Regenxbio Inc

regenxbio is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (aav) gene therapy. regenxbio's nav® technology platform, a proprietary aav gene delivery platform, consists of exclusive rights to more than 100 novel aav vectors, including aav7, aav8, aav9 and aavrh10. regenxbio's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on regenxbio's nav technology platform. regenxbio seeks to accomplish this mission through a combination of internal development efforts and third‐party nav technology platform licensees.
OrganisationRegenxbio Inc
Headquarters9804 Medical Center Drive, Rockville, MD, United States, 20850
IndustryHealth Technology
CEOMr. Curran M. Simpson M.S.
E-voting on sharesClick here to vote

Key Management of Regenxbio Inc

Name

Title

Mr. Patrick J. Christmas II, J.D.

Executive VP & Chief Strategy and Legal Officer

Dr. Stephen Pakola M.D.

Executive VP & Chief Medical Officer

Dr. Ram Palanki Pharm.D.

Executive VP & Chief Commercial Officer

Mr. Curran M. Simpson M.S.

President, CEO & Director

Mr. Mitchell Chan M.B.A.

Executive VP & CFO

Ms. Shiva G. Fritsch

Chief Communications & People Officer

Ms. Sarah Thomas

Senior Vice President of Quality

Dr. Jahannaz Dastgir D.O.

Clinical Development Lead

Dr. Olivier Danos Ph.D.

Executive VP & Chief Scientific Officer

Mr. Craig Malzahn

Executive VP of Product Development & CTO

FAQs

What is Regenxbio Inc share price today?

Regenxbio Inc share price today is $9.1 as on at the close of the market. Regenxbio Inc share today touched a day high of $9.35 and a low of $8.85.

What is the 52 week high and 52 week low for Regenxbio Inc share?

Regenxbio Inc share touched a 52 week high of $13.48 on and a 52 week low of $5.04 on . Regenxbio Inc stock price today i.e. is closed at $9.1,which is 32.49% down from its 52 week high and 80.73% up from its 52 week low.

What is Regenxbio Inc's market capitalisation today?

Regenxbio Inc market capitalisation is $0.00T as on .

How to invest in Regenxbio Inc Stock (RGNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Regenxbio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regenxbio Inc Shares that will get you 0.1648 shares as per Regenxbio Inc share price of $9.1 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Regenxbio Inc Stock (RGNX) from India?

Indian investors can start investing in Regenxbio Inc (RGNX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Regenxbio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Regenxbio Inc share’s latest price of $9.1 as on September 16, 2025 at 1:29 am IST, you will get 1.0989 shares of Regenxbio Inc. Learn more about fractional shares .

What are the returns that Regenxbio Inc has given to Indian investors in the last 5 years?

Regenxbio Inc stock has given -68.46% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?